This study investigates the suicidal ideation and the possible causes for suicidal behaviour in the elderly. Subjects were 150 patients aged 65 and older who were evaluated using the sociodemographic data collection forms, Geriatric Depression Scale (GDS), Suicidal Ideation Scale (SIS), Reasons for Living Inventory (RLI), and Beck Hopelessness Scale (BHS). Of 150 patients, 72.7% were women and 27.3% were men, ages ranged from 65 to 88 years. Suicidal ideation was noted in 30.7% of patients. When the mean of BHS total score between patients with and without suicidal ideation and the mean of BHS subscale’s feelings and expectations regarding the future and loss of motivation and hope in terms of subscales were evaluated between the groups with and without suicidal ideation, the scores had a significant difference. When RLI was evaluated in terms of total scores, the suicidal ideation mean score was 243.74 ± 32.28, while the non-suicidal ideation mean score was 267.27 ± 24.36. There was a significant relationship between the two groups. We found low level of education, low level of reasons for living and higher psychiatric morbidity (generalized anxiety disorder and comorbid depressive disorder) in with suicidal ideation in the elderly.
1 November 2013 in Complementary Therapies in Clinical Practice
Semaphorin 5A (SEMA 5A) is a neuroprotein that regulates the formation of excitatory synapses between neurons, important in autoimmunity, inflammatory processes and behaviors. This study aimed to i...
Objective: As the pandemic spreads worldwide, individuals are exposed to factors such as social isolation, economic uncertainty, and general stress, which has increased the risk of substance use and addiction. Studies show that the SARS-CoV-2 (COVID-19) pandemic has increased substance use disorders. The aim of this study is to examine the impact of the COVID-19 pandemic on substance use disorders.Method: The study was planned as a retrospective study. This study was based on March 11, 2020, the date when the COVID-19 case was first seen in Turkey, for 4 years, including two years before the pandemic and two years during the pandemic process, between 11.03.2018 and 11.03.2022. 1743 cases referred to the psychiatric outpatient clinic within the scope of probation were included.Results: While substance use was detected in 834 people in the pre-COVID-19 pandemic period (March 2018-March 2020), substance use was detected in 909 people during the COVID-19 pandemic period (March 2020-March 2022). A significant increase in substance use was detected in female gender during the pandemic period. A statistically significant increase was observed in methamphetamine, opioid, cocaine and multiple substance use during the pandemic period compared to the pre-pandemic period.Conclusion: The data of our study show substance use rates in Turkey before and during the pandemic. The study will be useful to understand the impact of COVID-19 on drug use frequencies in Türkiye.
30 September 2014 in Dusunen Adam: Journal of Psychiatry and Neurological Sciences